Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Böhmig GA[au]:

Search results

Items: 1 to 50 of 138

1.

Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients.

Aigner C, Böhmig GA, Eskandary F, Herkner H, Prohászka Z, Csuka D, Kain R, Gaggl M, Sunder-Plassmann R, Müller-Sacherer T, Oszwald A, Fischer G, Schmidt A, Sunder-Plassmann G.

Eur J Intern Med. 2019 Nov 29. pii: S0953-6205(19)30394-2. doi: 10.1016/j.ejim.2019.11.007. [Epub ahead of print]

PMID:
31791575
2.

A urinary metabolite constellation to detect acute rejection in kidney allografts.

Banas MC, Neumann S, Pagel P, Putz FJ, Krämer BK, Böhmig GA, Eiglsperger J, Schiffer E, Ruemmele P, Banas B.

EBioMedicine. 2019 Oct;48:505-512. doi: 10.1016/j.ebiom.2019.10.007. Epub 2019 Oct 21.

3.

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection.

Mező B, Heilos A, Böhmig GA, Eskandary F, Wahrmann M, Bond G, Kozakowski N, Halloran PF, Rusai K, Prohászka Z.

Transplant Direct. 2019 Jun 27;5(7):e470. doi: 10.1097/TXD.0000000000000915. eCollection 2019 Jul.

4.

Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation.

Kovarik JJ, Kaltenecker CC, Kopecky C, Domenig O, Antlanger M, Werzowa J, Eskandary F, Kain R, Poglitsch M, Schmaldienst S, Böhmig GA, Säemann MD.

Sci Rep. 2019 Jul 5;9(1):9762. doi: 10.1038/s41598-019-46114-x.

5.

CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation.

Wieser M, Francisci T, Lackner D, Buerckstuemmer T, Wasner K, Eilenberg W, Stift A, Wahrmann M, Böhmig GA, Grillari J, Grillari-Voglauer R.

PLoS One. 2019 Apr 8;14(4):e0214514. doi: 10.1371/journal.pone.0214514. eCollection 2019.

6.

The therapeutic challenge of late antibody-mediated kidney allograft rejection.

Böhmig GA, Eskandary F, Doberer K, Halloran PF.

Transpl Int. 2019 Aug;32(8):775-788. doi: 10.1111/tri.13436. Epub 2019 May 7. Review.

7.

Effects of immunoadsorption combined with membrane filtration on complement markers - results of a randomized, controlled, crossover study.

Defendi F, Malvezzi P, Eskandary F, Cesbron JY, Rostaing L, Böhmig GA, Dumestre-Pérard C.

Transpl Int. 2019 Aug;32(8):876-883. doi: 10.1111/tri.13431. Epub 2019 Apr 5.

PMID:
30901502
8.

Generating automated kidney transplant biopsy reports combining molecular measurements with ensembles of machine learning classifiers.

Reeve J, Böhmig GA, Eskandary F, Einecke G, Gupta G, Madill-Thomsen K, Mackova M, Halloran PF; INTERCOMEX MMDx-Kidney Study Group.

Am J Transplant. 2019 Oct;19(10):2719-2731. doi: 10.1111/ajt.15351. Epub 2019 Apr 10.

PMID:
30868758
9.

Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients.

Strassl R, Doberer K, Rasoul-Rockenschaub S, Herkner H, Görzer I, Kläger JP, Schmidt R, Haslacher H, Schiemann M, Eskandary FA, Kikić Ž, Reindl-Schwaighofer R, Puchhammer-Stöckl E, Böhmig GA, Bond G.

J Infect Dis. 2019 May 24;219(12):1934-1939. doi: 10.1093/infdis/jiz039.

10.

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial.

Eskandary F, Dürr M, Budde K, Doberer K, Reindl-Schwaighofer R, Waiser J, Wahrmann M, Regele H, Spittler A, Lachmann N, Firbas C, Mühlbacher J, Bond G, Halloran PF, Chong E, Jilma B, Böhmig GA.

Trials. 2019 Jan 11;20(1):37. doi: 10.1186/s13063-018-3158-6.

11.

Extracorporeal immunoadsorption in heparin- and protamine-induced thrombocytopaenia prior to cardiac surgery.

Füreder L, Böhmig GA, Schaefer AK, Steinlechner B.

Eur J Cardiothorac Surg. 2019 Jul 1;56(1):206-207. doi: 10.1093/ejcts/ezy411.

PMID:
30541064
12.

Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation - a prospective trial.

Burghuber CK, Kandioler D, Strobl S, Mittlböck M, Böhmig GA, Soliman T, Berlakovich GA.

Transpl Int. 2019 Jan;32(1):59-65. doi: 10.1111/tri.13329. Epub 2018 Sep 3.

PMID:
30099769
13.

Allograft rejection is associated with development of functional IgE specific for donor MHC antigens.

Farkas AM, Baranyi U, Böhmig GA, Unger L, Hopf S, Wahrmann M, Regele H, Mahr B, Schwarz C, Hock K, Pilat N, Kristo I, Mraz J, Lupinek C, Thalhamer J, Bond G, Kuessel L, Wlodek E, Martin J, Clatworthy M, Pettigrew G, Valenta R, Wekerle T.

J Allergy Clin Immunol. 2019 Jan;143(1):335-345.e12. doi: 10.1016/j.jaci.2018.06.034. Epub 2018 Aug 9.

14.

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients.

Strassl R, Schiemann M, Doberer K, Görzer I, Puchhammer-Stöckl E, Eskandary F, Kikic Ž, Gualdoni GA, Vossen MG, Rasoul-Rockenschaub S, Herkner H, Böhmig GA, Bond G.

J Infect Dis. 2018 Sep 8;218(8):1191-1199. doi: 10.1093/infdis/jiy306.

15.

Novel Approaches to Block Complement.

Böhmig GA, Wahrmann M, Eskandary F, Rostaing L.

Transplantation. 2018 Nov;102(11):1837-1843. doi: 10.1097/TP.0000000000002267. Review.

PMID:
29870459
16.

Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation.

Arnold ML, Kainz A, Hidalgo LG, Eskandary F, Kozakowski N, Wahrmann M, Haslacher H, Oberbauer R, Heilos A, Spriewald BM, Halloran PF, Böhmig GA.

Am J Transplant. 2018 Sep;18(9):2261-2273. doi: 10.1111/ajt.14710. Epub 2018 Mar 30.

17.

Single-antigen Bead Assays to Define Unacceptable Antigen Mismatches?

Böhmig GA, Hidalgo LG.

Transplantation. 2018 Jun;102(6):894-895. doi: 10.1097/TP.0000000000002128. No abstract available.

PMID:
29438141
18.

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.

Eskandary F, Regele H, Baumann L, Bond G, Kozakowski N, Wahrmann M, Hidalgo LG, Haslacher H, Kaltenecker CC, Aretin MB, Oberbauer R, Posch M, Staudenherz A, Handisurya A, Reeve J, Halloran PF, Böhmig GA.

J Am Soc Nephrol. 2018 Feb;29(2):591-605. doi: 10.1681/ASN.2017070818. Epub 2017 Dec 14.

19.

Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes.

Küssel L, Herkner H, Wahrmann M, Eskandary F, Doberer K, Binder J, Pateisky P, Zeisler H, Böhmig GA, Bond G.

Sci Rep. 2017 Oct 19;7(1):13524. doi: 10.1038/s41598-017-13275-6.

20.

Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial.

Eskandary F, Jilma B, Mühlbacher J, Wahrmann M, Regele H, Kozakowski N, Firbas C, Panicker S, Parry GC, Gilbert JC, Halloran PF, Böhmig GA.

Am J Transplant. 2018 Apr;18(4):916-926. doi: 10.1111/ajt.14528. Epub 2017 Oct 31.

21.

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial.

Mühlbacher J, Jilma B, Wahrmann M, Bartko J, Eskandary F, Schörgenhofer C, Schwameis M, Parry GC, Gilbert JC, Panicker S, Böhmig GA.

Transplantation. 2017 Oct;101(10):2410-2418. doi: 10.1097/TP.0000000000001804.

22.

Transplantation: IdeS to desensitize organ allograft recipients.

Böhmig GA, Rostaing L.

Nat Rev Nephrol. 2017 Nov;13(11):666-668. doi: 10.1038/nrneph.2017.128. Epub 2017 Sep 11. No abstract available.

PMID:
28890539
23.

Clinical Case Discussion: Kidney Cancer in Transplanted Kidney: The Interdisciplinary Nephrologic-Urologic View.

Böhmig GA, Klatte T.

Eur Urol Focus. 2016 Jun;2(2):223-224. doi: 10.1016/j.euf.2016.01.004. Epub 2016 Feb 3.

PMID:
28723541
24.

Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes.

Reeve J, Böhmig GA, Eskandary F, Einecke G, Lefaucheur C, Loupy A, Halloran PF; MMDx-Kidney study group.

JCI Insight. 2017 Jun 15;2(12). pii: 94197. doi: 10.1172/jci.insight.94197. eCollection 2017 Jun 15.

25.

Impact of ultrasound examination shortly after kidney transplantation.

Schwarz C, Mühlbacher J, Böhmig GA, Purtic M, Pablik E, Unger L, Kristo I, Soliman T, Berlakovich GA.

Eur Surg. 2017;49(3):140-144. doi: 10.1007/s10353-017-0467-z. Epub 2017 Feb 16.

26.

Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study.

Halloran PF, Reeve J, Akalin E, Aubert O, Bohmig GA, Brennan D, Bromberg J, Einecke G, Eskandary F, Gosset C, Duong Van Huyen JP, Gupta G, Lefaucheur C, Malone A, Mannon RB, Seron D, Sellares J, Weir M, Loupy A.

Am J Transplant. 2017 Nov;17(11):2851-2862. doi: 10.1111/ajt.14329. Epub 2017 May 30.

27.

Diffuse Extent of Peritubular Capillaritis in Late Antibody-Mediated Rejection: Associations With Levels of Donor-Specific Antibodies and Chronic Allograft Injury.

Kozakowski N, Eskandary F, Herkner H, Bond G, Oberbauer R, Regele H, Böhmig GA, Kikić Ž.

Transplantation. 2017 May;101(5):e178-e187. doi: 10.1097/TP.0000000000001707.

PMID:
28252564
28.

Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study.

Wahrmann M, Mühlbacher J, Marinova L, Regele H, Huttary N, Eskandary F, Cohen G, Fischer GF, Parry GC, Gilbert JC, Panicker S, Böhmig GA.

Am J Transplant. 2017 Sep;17(9):2300-2311. doi: 10.1111/ajt.14256. Epub 2017 Mar 31.

29.

Czech-Austrian kidney paired donation: first European cross-border living donor kidney exchange.

Böhmig GA, Fronek J, Slavcev A, Fischer GF, Berlakovich G, Viklicky O.

Transpl Int. 2017 Jun;30(6):638-639. doi: 10.1111/tri.12945. Epub 2017 Apr 10. No abstract available.

30.

The Effect of Cortex/Medulla Proportions on Molecular Diagnoses in Kidney Transplant Biopsies: Rejection and Injury Can Be Assessed in Medulla.

Madill-Thomsen KS, Wiggins RC, Eskandary F, Böhmig GA, Halloran PF.

Am J Transplant. 2017 Aug;17(8):2117-2128. doi: 10.1111/ajt.14233. Epub 2017 Mar 23.

31.

Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation.

Schiemann M, Puchhammer-Stöckl E, Eskandary F, Kohlbeck P, Rasoul-Rockenschaub S, Heilos A, Kozakowski N, Görzer I, Kikić Ž, Herkner H, Böhmig GA, Bond G.

Transplantation. 2017 Feb;101(2):360-367. doi: 10.1097/TP.0000000000001455.

32.

Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.

Schwaiger E, Eskandary F, Kozakowski N, Bond G, Kikić Ž, Yoo D, Rasoul-Rockenschaub S, Oberbauer R, Böhmig GA.

Nephrol Dial Transplant. 2016 Aug;31(8):1342-51. doi: 10.1093/ndt/gfw027. Epub 2016 Mar 24.

PMID:
27190362
33.

Kidney Transplantation With Corticosteroids Alone After Haploidentical HSCT From The Same Donor.

Schwarz C, Lawitschka A, Böhmig GA, Dauber EM, Greinix H, Kozakowski N, Mühlbacher F, Berlakovich GA, Wekerle T.

Transplantation. 2016 Oct;100(10):2219-21. doi: 10.1097/TP.0000000000001213.

PMID:
27136263
34.

Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.

Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA.

Transplantation. 2017 Mar;101(3):631-641. doi: 10.1097/TP.0000000000001195.

PMID:
27120452
35.

Metallothioneins and renal ageing.

Leierer J, Rudnicki M, Braniff SJ, Perco P, Koppelstaetter C, Mühlberger I, Eder S, Kerschbaum J, Schwarzer C, Schroll A, Weiss G, Schneeberger S, Wagner S, Königsrainer A, Böhmig GA, Mayer G.

Nephrol Dial Transplant. 2016 Sep;31(9):1444-52. doi: 10.1093/ndt/gfv451. Epub 2016 Feb 3.

PMID:
26908771
36.

Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d.

Hofer J, Forster F, Isenman DE, Wahrmann M, Leitner J, Hölzl MA, Kovarik JJ, Stockinger H, Böhmig GA, Steinberger P, Zlabinger GJ.

FASEB J. 2016 Apr;30(4):1492-503. doi: 10.1096/fj.15-275594. Epub 2015 Dec 17.

PMID:
26678451
37.

Complement inhibition as potential new therapy for antibody-mediated rejection.

Eskandary F, Wahrmann M, Mühlbacher J, Böhmig GA.

Transpl Int. 2016 Apr;29(4):392-402. doi: 10.1111/tri.12706. Epub 2015 Nov 10. Review.

38.

Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy.

Werzowa J, Schwaiger B, Hecking M, Strassl R, Schmaldienst S, Böhmig GA, Genser B, Säemann MD.

Clin Transplant. 2015 Dec;29(12):1230-8. doi: 10.1111/ctr.12657. Epub 2015 Nov 25.

PMID:
26458731
39.

Strategies to overcome the ABO barrier in kidney transplantation.

Böhmig GA, Farkas AM, Eskandary F, Wekerle T.

Nat Rev Nephrol. 2015 Dec;11(12):732-47. doi: 10.1038/nrneph.2015.144. Epub 2015 Sep 1. Review.

PMID:
26324199
40.

Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?

Böhmig GA, Kikic Z, Wahrmann M, Eskandary F, Aliabadi AZ, Zlabinger GJ, Regele H, Feucht HE.

Clin Biochem. 2016 Mar;49(4-5):394-403. doi: 10.1016/j.clinbiochem.2015.05.024. Epub 2015 Jun 26. Review.

PMID:
26118475
41.

Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.

Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1435-43. doi: 10.2215/CJN.09901014. Epub 2015 Jun 12.

42.

Surface Plasmon Resonance Analysis Shows an IgG-Isotype-Specific Defect in ABO Blood Group Antibody Formation in Patients with Common Variable Immunodeficiency.

Fischer MB, Wolfram W, Binder CJ, Böhmig GA, Wahrmann M, Eibl MM, Wolf HM.

Front Immunol. 2015 May 6;6:211. doi: 10.3389/fimmu.2015.00211. eCollection 2015.

43.

Effect of combined treatment with immunoadsorption and membrane filtration on plasma coagulation--Results of a randomized controlled crossover study.

Biesenbach P, Eskandary F, Ay C, Wiegele M, Derfler K, Schaden E, Haslacher H, Oberbauer R, Böhmig GA.

J Clin Apher. 2016 Feb;31(1):29-37. doi: 10.1002/jca.21399. Epub 2015 Apr 28.

PMID:
25919120
44.

The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss.

Kozakowski N, Herkner H, Böhmig GA, Regele H, Kornauth C, Bond G, Kikić Ž.

Kidney Int. 2015 Aug;88(2):332-40. doi: 10.1038/ki.2015.64. Epub 2015 Mar 4.

45.

Long-term outcome of belatacept therapy in de novo kidney transplant recipients - a case-match analysis.

Schwarz C, Mayerhoffer S, Berlakovich GA, Steininger R, Soliman T, Watschinger B, Böhmig GA, Eskandary F, König F, Mühlbacher F, Wekerle T.

Transpl Int. 2015 Jul;28(7):820-7. doi: 10.1111/tri.12544. Epub 2015 Mar 6.

46.

[Kidney paired donation. Combination with extracorporeal desensitization].

Bond G, Böhmig GA.

Med Klin Intensivmed Notfmed. 2014 Sep;109(6):408-10. doi: 10.1007/s00063-014-0363-2. Epub 2014 Aug 23. Review. German.

PMID:
25146557
47.

Rejection despite C5 blockade: a distinct role of IgM?

Böhmig GA, Eskandary F.

Transpl Int. 2014 Dec;27(12):1233-4. doi: 10.1111/tri.12407. No abstract available.

48.

Gender has no influence on VUR rates after renal transplantation.

Farr A, Györi G, Mühlbacher F, Husslein P, Böhmig GA, Margreiter M.

Transpl Int. 2014 Nov;27(11):1152-8. doi: 10.1111/tri.12397.

49.

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial.

Eskandary F, Bond G, Schwaiger E, Kikic Z, Winzer C, Wahrmann M, Marinova L, Haslacher H, Regele H, Oberbauer R, Böhmig GA.

Trials. 2014 Apr 3;15:107. doi: 10.1186/1745-6215-15-107.

50.

Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads.

Schwaiger E, Wahrmann M, Bond G, Eskandary F, Böhmig GA.

Transplantation. 2014 Jun 27;97(12):1279-85. doi: 10.1097/01.TP.0000441091.47464.c6.

PMID:
24621535

Supplemental Content

Loading ...
Support Center